Effects of dopamine, dobutamine, amrinone and milrinone on regional blood flow in isoflurane anesthetized dogs

Journal of Veterinary Medical Science

Volumn 66, Issue 9, 2004, Pages 1097-1105

  Tobata, Denji ^a   Takao, Koji ^a   Mochizuki, Manabu ^a   Nishimura, Ryohei ^a   Sasaki, Nobuo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amrinone; Canine; Dobutamine; Dopamine; Milrinone

Indexed keywords

CANIS FAMILIARIS;

AMRINONE; CARDIOTONIC AGENT; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; ISOFLURANE; MICROSPHERE; MILRINONE; PHOSPHODIESTERASE INHIBITOR;

ANIMAL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BRAIN; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; DIGESTIVE SYSTEM; DOG; DRUG EFFECT; EYE; LUNG; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION;

AMRINONE; ANIMALS; BLOOD PRESSURE; BRAIN; CARDIOTONIC AGENTS; CATECHOLAMINES; CORONARY CIRCULATION; DIGESTIVE SYSTEM; DOBUTAMINE; DOGS; DOPAMINE; EYE; ISOFLURANE; LUNG; MICROSPHERES; MILRINONE; MUSCLE, SKELETAL; PHOSPHODIESTERASE INHIBITORS; REGIONAL BLOOD FLOW;

EID: 16544384887     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.66.1097     Document Type: Article

References (39)

1. Alousi, A. A., Canter, J. M., Montenaro, M. J., Fort, D. J. and Ferrari, R. A. 1983. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals. J. Cardiovasc. Pharmacol. 5: 792-803.
2. Alousi, A. A., Farah, A. E., Lesher, G. Y. and Opalka, C. J., Jr. 1979. Cardiotonic activity of amrinone - Win 40680 [5-amino-3,4′-bipyridine- 6(1H)-one]. Circ. Res. 45: 666-677.
3. Bernard, J. M., Wouters, P. F., Doursout, M. F., Florence, B., Chelly, J. E. and Merin, R. G. 1990. Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology 72: 659-662.
4. Boncyk, J., Redon, D. and Rusy, B. 1984. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine. Res. Commun. Chem. Pathol. Pharmacol. 44: 347-354.
5. Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C. and Stinson, E. B. 1982. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. New Engl. J. Med. 307: 205-211.
6. Colucci, W. S., Wright, R. F., Jaski, B. E., Fifer, M. A. and Braunwald, E. 1986. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 73: III175-183
7. Dai, X. Z., Chen, D. G. and Bache, R. J. 1989. Alpha-adrenergic effects of dopamine and dobutamine on the coronary circulation. J. Cardiovasc. Pharmacol. 14: 82-87.
8. Endoh, M., Yanagisawa, T., Taira, N. and Blinks, J. R. 1986. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73: III117-133.
9. Fan, F. C., Schuessler, G. B., Chen, R. Y. and Chien, S. 1979. Determinations of blood flow and shunting of 9- and 15-micrometer spheres in regional beds. Am. J. Physiol. 237: H25-33.
10. Fukui, H. and Yazaki, S. 1986. Effect of different doses of dopamine or dobutamine on hemodynamics and plasma norepinephrine concentrations in dogs with pulmonary edema. Masui 35: 905-916 (in Japanese with English abstract).
11. Gelman, S., Fowler, K. C. and Smith, L. R. 1984. Regional blood flow during isoflurane and halothane anesthesia. Anesth. Analg. 63: 557-565.
12. Goldberg, L. I. 1972. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol. Rev. 24: 1-29.
13. Harris, A. L., Grant, A. M., Silver, P. J., Evans, D. B. and Alousi, A. A. 1989. Differential vasorelaxant effects of milrinone and amrinone on contractile responses of canine coronary, cerebral, and renal arteries. J. Cardiovasc. Pharmacol. 13: 238-244.
14. Heymann, M. A., Payne, B. D., Hoffman, J. I. and Rudolph, A. M. 1977. Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovasc. Dis. 20: 55-79.
15. Hodeige, D., de Pauw, M., Eechaute, W., Weyne, J. and Heyndrickx, G. R. 1999. On the validity of blood flow measurement using colored microspheres. Am. J. Physiol. 276: H1150-1158.
16. Holmes, J. C. and Fowler, N. O. 1962. Direct cardiac effect of dopamine. Circ. Res. 10: 68-72.
17. Kato, R., Sato, J. and Nishino, T. 1998. Milrinone decreases both pulmonary arterial and venous resistances in the hypoxic dog. Br. J. Anaesth. 81: 920-924.
18. Kinoshita, G., Washizu, M., Murata, N., Kondo, M., Matsukura, Y., Washizu, T. and Motoyoshi, S. 1995. The effects of dopamine and dobutamine on liver oxygen supply-uptake relationship in the dog. J. Vet. Med. Sci. 57: 287-291.
19. Kopia, G. A. and Valocik, R. E. 1989. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog. J. Pharmacol. Exp. Ther. 248: 215-221.
20. Lee, J. G., Hudetz, A. G., Smith, J. J., Hillard, C. J., Bosnjak, Z. J. and Kampine, J. P. 1994. The effects of halothane and isoflurane on cerebrocortical microcirculation and autoregulation as assessed by laser-Doppler flowmetry. Anesth. Analg. 79: 58-65.
21. Matsumoto, N., Koizumi, M. and Sugai, M. 1999. Hepatolobectomy-induced depression of hepatic circulation and metabolism in the dog is counteracted by isoflurane, but not by halothane. Acta Anaesthesiol. Scand. 43: 850-854.
22. Mazoit, J. X., Le Guen, R., Decaux, A., Albaladejo, P. and Samii, K. 1998. Application of HPLC to counting of colored microspheres in determination of regional blood flow. Am. J. Physiol. 274: H1041-1047.
23. McNay, J. L., McDonald, R. H. and Goldberg, L. I. 1965. Direct renal vasodilation produced by dopamine in the dog. Circ. Res. 16: 510-517.
24. Morishita, H. and Furukawa, T. 1980. Possible modes of action of dobutamine in dog femoral and pulmonary arteries. Cardiovasc. Res. 14: 103-107.
25. Nash, C. W., Wolff, S. A. and Ferguson, B. A. 1968. Release of tritiated noradrenaline from perfused rat hearts by sympathomimetic amines. Can. J. Physiol. Pharmacol. 46: 35-42.
26. Ogawa, R. 1999. Distributive shock and it's therapy by cardiovascular acting drugs. Nippon Geka Gakkai Zasshi 100: 679-682 (in Japanese with English summary).
27. Ozaki, N., Kawakita, S. and Toda, N. 1982. Effects of dobutamine on isolated canine cerebral, coronary, mesenteric, and renal arteries. J. Cardiovasc. Pharmacol. 4: 456-461.
28. Robie, N. W. and Goldberg, L. I. 1975. Comparative systemic and regional hemodynamic effects of dopamine and dobutamine. Am. Heart. J. 90: 340-345.
29. Serikov, V. B. and Fleming, N. W. 2001. Pulmonary and bronchial circulations: contributions to heat and water exchange in isolated lungs. J. Appl. Physiol. 91: 1977-1985.
30. Silver, P. J., Harris, A. L., Fort, D. J., Perrone, M. H. and Evans, D. B. 1987. Effects of the Cardiovascular agents amrinone and milrinone on phosphodiesterase (PDE) isozymes and contractile force in guinea pig cardiac and vascular tissue. Federation Proceedings 46: 373.
31. Tobata, D., Takao, K., Mochizuki, M., Nishimura, R. and Sasaki, N. 2003. Cardiopulmonary effects of dopamine, dobutamine, amrinone and milrinone in isoflurane-anesthetized Dogs. Jpn. J. Vet. Aneth. Surg. 34: 89-96 (in Japanese with English summary).
32. Turtle, R. R. and Mills, J. 1975. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ. Res. 36: 185-196.
33. Vasu, M. A., O'Keefe, D. D., Kapellakis, G. Z., Vezeridis, M. P., Jacobs, M. L., Daggett, W. M. and Powell, W. J., Jr. 1978. Myocardial oxygen consumption: effects of epinephrine, isoproterenol, dopamine, norepinephrine, and dobutamine. Am. J. Physiol. 235: H237-241.
34. von Essen, C., Zervas, N. T., Brown, D. R., Koltun, W. A. and Pickren, K. S. 1980. Local cerebral blood flow in the dog during intravenous infusion of dopamine. Surg. Neurol. 13: 181-188.
35. Wagner, J. G. 1974. A safe method for rapidly achieving plasma concentration plateaus. Clin. Pharmacol. Ther. 16: 691-700.
36. Walter, B., Bauer, R., Gaser, E. and Zwiener, U. 1997. Validation of multiple colored microsphere technique for measurements in newborn piglets. Basic. Res. Cardiol. 92: 191-200.
37. Weishaar, R. E., Burrows, S. D., Kobylarz, D. C., Quade, M. M. and Evans, D. B. 1986. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem. Pharmacol. 35: 787-800.
38. Yano, H. and Takaori, M. 1994. The microcirculation during enflurane and isoflurane anaesthesia in dogs. Can. J. Anaesth. 41: 149-155.
39. Yeh, B. K., McNay, J. L. and Goldberg, L. I. 1969. Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J. Pharmacol. Exp. Ther. 168: 303-309.